nuvationbio
The Director, Research at Nuvation Bio oversees the strategic and operational management of research activities to advance the company's discovery portfolio from candidate selection to clinical development. This role involves leading the Pharmacology function and collaborating with multiple research teams and other departments to support the company's pipeline progression and portfolio expansion.
Headquarters
New York, New York, United States
Company Size
51-200 employees
Founded
2018
NUVATION BIO, INC. is a global oncology company driven by science, focused on tackling some of the toughest challenges in cancer treatment. The company aims to discover and develop novel cancer therapies by leveraging translational science and a disciplined, data-driven approach to build a robust pipeline. Led by founder and Chief Executive Officer David Hung, M.D., Nuvation Bio pursues strategic collaborations and rigorous development to deliver meaningful clinical outcomes for patients. Its mission centers on advancing transformative oncology programs through rigorous research, partnerships, and patient-centric priorities.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for nuvationbio.
16% below the average for this role
Director/Senior Director, In Vivo Pharmacology
Rezo Therapeutics
Research Associate
Novo Nordisk A/S
Sr. Director, Pharmacology
Cellarity
Principal Scientist – Cardiometabolic Diseases/Obesity Research
Amgen
Sr. Director, Pharmacology
Flagship Pioneering, Inc.
Snr Scientist II / Principal Scientist, In Vivo Biology & Translational Science
Relation Therapeutics